| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,172 |
13,681 |
$2.20M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,028 |
1,773 |
$660K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,849 |
2,484 |
$355K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
486 |
452 |
$142K |
| 71045 |
Radiologic examination, chest; single view |
1,007 |
891 |
$50K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,091 |
936 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
436 |
405 |
$38K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
348 |
190 |
$30K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
420 |
407 |
$22K |
| 59025 |
Fetal non-stress test |
169 |
103 |
$22K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
190 |
147 |
$8K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
31 |
29 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
55 |
52 |
$7K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
276 |
249 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
49 |
49 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
186 |
52 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
43 |
40 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
16 |
15 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
34 |
30 |
$891.41 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,423 |
7,283 |
$527.40 |
| 87400 |
|
347 |
304 |
$523.20 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
55 |
43 |
$515.67 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,749 |
1,565 |
$251.39 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,906 |
2,427 |
$196.22 |
| Q3014 |
Telehealth originating site facility fee |
13 |
12 |
$159.99 |
| 81003 |
|
1,547 |
1,378 |
$126.47 |
| 36415 |
Collection of venous blood by venipuncture |
7,094 |
6,076 |
$60.93 |
| 80053 |
Comprehensive metabolic panel |
7,842 |
6,805 |
$38.61 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
12 |
$30.99 |
| 83735 |
|
234 |
208 |
$24.54 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
110 |
64 |
$17.87 |
| 84703 |
|
429 |
384 |
$8.83 |
| 81001 |
|
55 |
49 |
$3.72 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
139 |
122 |
$0.00 |
| 80305 |
|
1,013 |
874 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
293 |
248 |
$0.00 |
| 85610 |
|
395 |
355 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,741 |
3,287 |
$0.00 |
| 83690 |
|
615 |
553 |
$0.00 |
| 83880 |
|
378 |
333 |
$0.00 |
| 82550 |
|
582 |
509 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
416 |
372 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
62 |
61 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
265 |
205 |
$0.00 |
| 82553 |
|
552 |
482 |
$0.00 |
| 84484 |
|
1,011 |
813 |
$0.00 |
| 87088 |
|
30 |
26 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16 |
12 |
$0.00 |
| 85730 |
|
90 |
88 |
$0.00 |
| 85379 |
|
18 |
14 |
$0.00 |